PMEL and cancer: Specifically, we found novel splicing in melanocyte-specific transmembrane glycoprotein (PMEL) in the melanoma cell lines, which was further confirmed by qPCR and may be crucial for cancer proliferation and, thus, be targeted by novel therapeutic approaches.